These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29540332)

  • 1. Delayed reaction following gadolinium-based contrast agent application.
    Boehm I; Heverhagen JT
    Magn Reson Imaging; 2018 Jul; 50():10-11. PubMed ID: 29540332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
    Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
    Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
    Boehm I; Hungerbühler M; Heverhagen JT
    Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
    Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
    Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
    Carr TF
    Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
    Heshmatzadeh Behzadi A; Prince MR
    Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial.
    Walker D; McGrath TA; Glikstein R; Chakraborty S; Blanchette C; Schieda N
    Invest Radiol; 2021 Jun; 56(6):369-373. PubMed ID: 33337738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions to Both Nonionic Iodinated and Gadolinium-Based Contrast Media: Incidence and Clinical Characteristics.
    Sodagari F; Mozaffary A; Wood CG; Schmitz B; Miller FH; Yaghmai V
    AJR Am J Roentgenol; 2018 Apr; 210(4):715-719. PubMed ID: 29412016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
    Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
    Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.
    Bansie RD; Karim AF; van Maaren MS; Hermans MA; van Daele P; Gerth van Wijk R; Rombach SM
    Int J Immunopathol Pharmacol; 2021; 35():20587384211015061. PubMed ID: 34053316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
    Aran S; Shaqdan KW; Abujudeh HH
    Clin Radiol; 2015 May; 70(5):466-75. PubMed ID: 25626627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
    Thomsen HS
    Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity reaction after oral intake of non-ionic iodinated contrast medium.
    Peters AA; Heverhagen JT; Boehm IB
    Acta Clin Belg; 2022 Aug; 77(4):785-786. PubMed ID: 34556010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A delayed reaction to the magnetic resonance imaging contrast agent gadobutrol.
    Nagai H; Nishigori C
    J Allergy Clin Immunol Pract; 2017; 5(3):850-851. PubMed ID: 28153713
    [No Abstract]   [Full Text] [Related]  

  • 16. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
    Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
    PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
    Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC
    Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
    Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
    Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective evaluation of acute adverse events and image quality of gadolinium-based contrast agents (gadobutrol and gadobenate dimeglumine) by blinded evaluation. Pilot study.
    Semelka RC; Hernandes Mde A; Stallings CG; Castillo M
    Magn Reson Imaging; 2013 Jan; 31(1):96-101. PubMed ID: 22898688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramagnetic Contrast Media: Hypersensitivity and Cross-Reactivity.
    Moreno Escobosa MC; Cruz Granados S
    J Investig Allergol Clin Immunol; 2018; 28(1):60-62. PubMed ID: 29461215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.